← Eichor
Study identifier: NCT07732166 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Changes in Self-awareness Induced by Psychoactive Substances: an Experimental Study With Psilocybin.

Condition: Healthy Adults  ·  Sponsor: Pontifícia Universidade Católica do Rio de Janeiro

PhaseEARLY_Phase 1
Planned participants100
Who can joinAll sexes, 21 Years to 60 Years
Healthy volunteersYes

About this study

Self-awareness, the capacity of becoming the object of one's own awareness, is a frontier of scientific knowledge. Over centuries, distinct philosophical and religious traditions have grappled with the subject, but only recently has the importance of self-awareness been established as a central concept for scientific investigation, to which scientific methods can be applied to explore and characterize this phenomenon. Self-awareness has important implications, notably from a clinical perspective. Psychedelics can affect the sense of self, with 'ego dissolution' being an essential feature of the experience of substances such as psilocybin and dimethyltryptamine. Recent evidence indicates that psychedelics can rearrange brain connectivity, with these changes being linked to alterations in self-awareness. Nevertheless, the extent to which specific components of self-awareness are modified by these substances has not been fully explored. It is possible that part of the clinical benefits of psychedelics, for conditions such as depression, OCD, and anxiety, is mediated by changes in self-awareness. Given this clinical potential, the current study aims to examine the effects of psilocybin on various components of self-awareness in healthy participants. 100 participants will be allocated to receive either 15mg of psilocybin (n=50) or an active placebo (100mg niacin; n=50). Participants will be assessed one week before, immediately after, and one week after the administration of the s…

This description comes directly from the study's public registry record.

Talk to the study team

Daniel C Mograbi, PhD  ·  + 55 21 35272505  ·  mograbilab@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Centro de Pesquisas Matteo RicciRio de Janeiro, Rio de Janeiro, BrazilRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07732166